Psyence Biomedical Ltd.
PBMWW- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001985062
No open-market purchases or sales by Psyence Biomedical Ltd. insiders were filed in the last 90 days; 19 institutions reported holding it in 13F filings for Q2 2026, worth $121.6K in total; no superinvestor holds it.
Other share classesPBM
Q1 2025 vs. Q4 2024
How the institutions holding Psyence Biomedical Ltd. changed between Q4 2024 and Q1 2025.
All holders in Q1 2025All holders in Q4 2024
| Measure | Q4 2024 | Q1 2025 | Change |
|---|---|---|---|
| Holders | 22 | 23 | +1 |
| Shares | 5.74M | 5.71M | −25.8K (−0.5%) |
| Value | $80.2K | $96.4K | +$16.3K (+20.3%) |
New holders (3)
Institutions that held Psyence Biomedical Ltd. at the end of Q1 2025 but not at the end of Q4 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| LPL Financial LLC | 29,345 | $496 | 0.00% |
| Susquehanna International Group, LLP | 20,923 | $354 | 0.00% |
| UBS Group AG | 1,589 | $27 | 0.00% |
Sold out (2)
Institutions that held Psyence Biomedical Ltd. at the end of Q4 2024 and filed for Q1 2025 without it.
| Institution | Shares, Q4 2024 | Value, Q4 2024 |
|---|---|---|
| Walleye Trading LLC | 44,080 | $635 |
| Walleye Capital LLC | 34,282 | $494 |